Month: March 2020

TORONTO, Canada, March 16, 2020 (GLOBE NEWSWIRE) — Canadian General Investments, Limited (the Company) (TSX:CGI) (TSX:CGI.PR.D) (LSE:CGI), announces that it has submitted its 2019 Annual Report, which includes the Management Report of Fund Performance and Audited Financial Statements and the 2020 Management Information Circular, including the Notice of Annual Meeting of Shareholders, Form of Proxy and Annual Information Form with applicable Canadian securities regulators and to the National Storage Mechanism (http://www.morningstar.co.uk/uk/NSM).PDF versions of these documents are also available at www.canadiangeneralinvestments.ca and at www.sedar.com.FOR FURTHER INFORMATION PLEASE CONTACT:Jonathan A. MorganPresident & CEOPhone: (416) 366-2931Fax: (416) 366-2729e-mail: cgifund@mmainvestments.comwebsite: www.canadiangenera...

Fourth quarter 2019 net income of $12.1 million, up from a loss of $7.3 million in prior year periodAdjusted EBITDA of $4.0 million for the quarter, up from $(0.5) million in prior year periodBacklog at $811.3 million, up 9.6% from beginning of 2019Cash flow from operations and free cash flow of $10.0 million and $6.1 million, respectively, for the year in 2019, compared to $(25.0) million and $(27.4) million, respectively, in prior year periodFiscal year 2020 consulting fee revenue projected between $330.0 million and $350.0 millionNet income margin and adjusted EBITDA margin of 15.8% and 5.2%, respectively, for the fourth quarter 2019, with projected EBITDA margin projected to increase to 5.5%-7.0% for 2020PHILADELPHIA, March 16, 2020 (GLOBE NEWSWIRE) — Hill International, Inc. (NYSE:HIL) (“Hill” or the “Company”),...

VANCOUVER, British Columbia, March 16, 2020 (GLOBE NEWSWIRE) — Rock Tech Lithium Inc. (the “Company” or “Rock Tech”) (TSX-V: RCK; Frankfurt: RJIB) is pleased to announce the appointment of Simon Bodensteiner to the position of President & Chief Executive Officer. Mr. Bodensteiner will also join the Company’s board of directors.“We are excited to be bolstering our in-house technical capabilities as we are further ramping up our activities at our Georgia Lake lithium project, entering into the next development phase of Rock Tech,” said Dirk Harbecke, the company’s chairman. Mr. Bodensteiner is a Mining Engineer with over 15 years of professional experience in Germany and Australia. He gained extensive knowledge in corporate, operational and technical roles and worked for both world-class firms, including Rio Tinto...

STAMFORD, Conn., March 16, 2020 (GLOBE NEWSWIRE) — Independence Holding Company (NYSE: IHC) announced that the Board of Directors has voted to increase the annual cash dividend by 10% to $.44 per share of common stock; and declared its semi-annual cash dividend of $.22 per share of common stock payable to stockholders of record on June 15, 2020, with a payment date of June 29th, 2020.Chief Executive Officer’s CommentsRoy T. K. Thung, Chief Executive Officer, commented, “IHC has a very strong balance sheet with no indebtedness, a very substantial amount of free cash at the corporate level and significant excess capital in our insurance companies. The amount of liquidity is more than enough to finance any future growth in the Company and to service any other liquidity needs.  This is IHC’s sixth increase in its dividend since December...

HAMPTON, N.H., March 16, 2020 (GLOBE NEWSWIRE) — Unitil Corporation (“Unitil” or the “Company”) (NYSE:UTL) (www.unitil.com) today announced the resignation of Christine L. Vaughan, Senior Vice President, Chief Financial Officer (“CFO”) and Treasurer, effective immediately. Ms. Vaughan resigned in order to pursue other professional opportunities.To ensure continuity, the Company has appointed Laurence M. Brock as the interim CFO and Treasurer until a new CFO and Treasurer has been named.  Mr. Brock is a seasoned finance and accounting professional with over 25 years of utility industry experience.  Mr. Brock has been Unitil’s Controller and Chief Accounting Officer since June 2005, and was Vice President and Controller from 1995 until 2005. Mr. Brock is a Certified Public Accountant in the state of New Hampshire.The Company also...

Dissident Stockholders Attempting to Gain Control of Company with Flawed Plan, Misrepresenting Company’s Progress for Own AgendaRecommends Stockholders Vote “FOR” Barnwell’s Slate of Highly Experienced Director Nomineeson the WHITE Proxy Card TodayHONOLULU, March 16, 2020 (GLOBE NEWSWIRE) — Barnwell Industries, Inc. (“Barnwell” or the “Company”) (NYSE American: BRN) today issued a factsheet for its stockholders, addressing the false and misleading statements made by a group of dissident stockholders, led by Ned Sherwood and Bradley Tirpak, who are trying to take control of the Company for their own, potentially self-serving agenda. At the Company’s Annual Meeting of Stockholders to be held on April 3, 2020, the Barnwell Board of Directors (the “Board”) recommends that stockholders support the current Barnwell team and strategy,...

-Firdapse® Q4 Net Revenues of $30 Million, FY 19 Net Revenues of $102 Million-GAAP Net Income of $32 Million for Fiscal Year 2019-Catalyst Reiterates Net Revenue Guidance in the Range of $135 Million to $155 Million for FY 2020-Firdapse Supply Chain in Solid Position-Significant Safety Stock-Company to Host Quarterly Conference Call at 8:30 am ET TomorrowCORAL GABLES, Fla., March 16, 2020 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq:CPRX), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, today reported financial results for the fourth quarter and year-ended December 31, 2019 and provided a corporate update.Patrick J. McEnany, Catalyst’s Chairman and CEO, stated: “2019...

MONTREAL, March 16, 2020 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX: GUD) (“Knight“) and Medison Biotech (1995) Ltd. (“Medison”) have closed today the previously disclosed transaction to separate their respective businesses.As announced on November 21, 2019, Knight and Medison have entered into a definitive agreement pursuant to which Knight will sell to the Medison group all of Knight’s shares in Medison, reflecting approximately 28.3% of the share capital of Medison, for $77,000,000 (“Consideration”).  Knight has received 75% ($57,750,000) of the Consideration and the remaining 25% ($19,250,000) will be held by a trustee and is expected to be released to Knight upon the issuance of a tax certificate by the Israel Tax Authority.About Knight Therapeutics Inc.Knight Therapeutics Inc., headquartered in Montreal,...